HIV-Associated Lipodystrophy Syndrome
"HIV-Associated Lipodystrophy Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.
| Descriptor ID |
D039682
|
| MeSH Number(s) |
C02.782.815.616.400.400 C02.800.801.400.400 C17.800.849.391.400 C18.452.584.625.400 C18.452.880.391.400 C20.673.480.400
|
| Concept/Terms |
HIV-Associated Lipodystrophy Syndrome- HIV-Associated Lipodystrophy Syndrome
- HIV Associated Lipodystrophy Syndrome
- Lipodystrophy Syndrome, HIV-Associated
- HIV Lipodystrophy Syndrome
- HIV-Associated Lipodystrophy
- HIV Associated Lipodystrophy
- Lipodystrophy, HIV-Associated
- Lipodystrophy Syndrome, HIV
|
Below are MeSH descriptors whose meaning is more general than "HIV-Associated Lipodystrophy Syndrome".
Below are MeSH descriptors whose meaning is more specific than "HIV-Associated Lipodystrophy Syndrome".
This graph shows the total number of publications written about "HIV-Associated Lipodystrophy Syndrome" by people in this website by year, and whether "HIV-Associated Lipodystrophy Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 2 | 3 |
| 2011 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV-Associated Lipodystrophy Syndrome" by people in Profiles.
-
Late Onset Complications Secondary to Polyacrylamide Hydrogel-Based Filler for Rehabilitation of HIV-Related Facial Lipoatropy. Aesthet Surg J. 2018 Oct 15; 38(11):NP170-NP174.
-
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). BMC Infect Dis. 2018 07 31; 18(1):357.
-
New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes. AIDS. 2017 07 17; 31(11):1535-1543.
-
Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 May 15; 64(10):1422-1429.
-
Mitochondrial damage in adipose tissue of untreated HIV-infected patients. AIDS. 2011 Jan 14; 25(2):165-70.
-
Short communication: HIV infection, antiretrovirals, and apoptosis: studies on skeletal muscle. AIDS Res Hum Retroviruses. 2005 Aug; 21(8):702-5.
-
Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study). J Acquir Immune Defic Syndr. 2005 Jan 01; 38(1):47-52.
-
Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy. Antivir Ther. 2005; 10 Suppl 2:M91-9.